Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00103805Phase 4Completed
A Phase 4 trial of levodopa in language disorder, sponsored by Universitätsklinikum Münster. Started Mar 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00103805.